1,211
Views
0
CrossRef citations to date
0
Altmetric
Pharmacology & Pharmaceutics

Glycemic control after sleeve gastrectomy in Taif Hospitals, Kingdom of Saudi Arabia

ORCID Icon, ORCID Icon, , , , , , & show all
Pages 602-607 | Received 03 Oct 2021, Accepted 06 Apr 2022, Published online: 24 May 2022

References

  • Ahmed A, Alanazi W, Ahmed R, AlJohi W, AlBuraikan D, AlRasheed B, ALMuqbil B, Al-Zahrani A, Yousef Z, AL-Jahdali H. 2018. The influences of bariatric surgery on hemoglobin A1C in a sample of obese patients in Saudi Arabia. Diabetes, Metab Syndr Obes Targets Ther. 11:271–276. doi:10.2147/DMSO.S161540.
  • Alenazi S, Koura H, Zaki S, Mohamed A. 2015. Prevalence of obesity among male adolescents in Arar Saudi Arabia: future risk of cardiovascular disease. Indian J Community Med. 40:182. doi:10.4103/0970-0218.158864.
  • American Diabetes Association. 2016. Obesity management for the treatment of type 2 diabetes. Sec. 6. In standards of medical care in diabetes. Diabetes Care. 39:S47–S51. doi:10.2337/dc16-S009.
  • Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. 2009. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 122:248–256. e5. doi:10.1016/j.amjmed.2008.09.041.
  • Cho J-M, Kim HJ, Lo ME, Park S, Szomstein S, Rosenthal RJ. 2015. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis. 11:1273–1280. doi:10.1016/j.soard.2015.03.001.
  • Cooiman MI, Aarts EO, Janssen IMC, Hazebroek EJ, Berends FJ. 2019. Weight loss, remission of comorbidities, and quality of life after bariatric surgery in young adult patients. Obes Surg. 29:1851–1857. doi:10.1007/s11695-019-03781-z.
  • de La Harpe R, Rüeger S, Kutalik Z, Ballabeni P, Suter M, Vionnet N, Laferrère B, Pralong F. 2020. Weight loss directly influences intermediate-term remission of diabetes mellitus after bariatric surgery: a retrospective case-control study. Obes Surg. 30:1332–1338. doi:10.1007/s11695-019-04283-8.
  • DeNicola E, Aburizaiza OS, Siddique A, Khwaja H, Carpenter DO. 2015. Obesity and public health in the Kingdom of Saudi Arabia. Rev Environ Health. 30. doi:10.1515/reveh-2015-0008.
  • DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L, Restuccia N, Yuen S, Fisk M, Inabnet WB, Bessler M. 2010. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 6:249–253. doi:10.1016/j.soard.2009.09.019.
  • Engin A. 2017. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 960:1–17. doi:10.1007/978-3-319-48382-5_1.
  • Faul F, Erdfelder E, Lang A-G, Buchner A. 2007. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 39:175–191. doi:10.3758/bf03193146.
  • Friedman AN, Wahed AS, Wang J, Courcoulas AP, Dakin G, Hinojosa MW, Kimmel PL, Mitchell JE, Pomp A, Pories WJ, et al. 2018. Effect of bariatric surgery on CKD risk. J Am Soc Nephrol. 29:1289–1300. doi:10.1681/ASN.2017060707.
  • Giordano S, Victorzon M. 2015. Bariatric surgery in elderly patients: asystematic review. Clin Interv Aging. 10:1627–1635. doi:10.2147/CIA.S70313.
  • Heneghan HM, Nissen S, Schauer PR. 2012. Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia. Curr Atheroscler Rep. 14:579–587. doi:10.1007/s11883-012-0285-5.
  • Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. 2001. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 345:790–797. doi:10.1056/NEJMoa010492.
  • Jindal R, Gupta M, Ahuja A, Nain P, Sharma P, Aggarwal A. 2020. Factors determining diabetic remission after sleeve gastrectomy: a prospective study. Niger J Surg. 26:66–71. doi:10.4103/njs.NJS_9_19.
  • Jurowich C, Thalheimer A, Hartmann D, Bender G, Seyfried F, Germer CT, Wichelmann C. 2012. Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery – who fails in the early postoperative course? Obes Surg. 22:1521–1526. doi:10.1007/s11695-012-0676-2.
  • Kantharidis P, Wang B, Carew RM, Lan HY. 2011. Diabetes complications: the microRNA perspective. Diabetes. 60:1832–1837. doi:10.2337/db11-0082.
  • Kaska L, Sledzinski T, Chomiczewska A, Dettlaff-Pokora A, Swierczynski J. 2016. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol. 22:8698. doi:10.3748/wjg.v22.i39.8698.
  • Kautzky-Willer A, Harreiter J, Pacini G. 2016. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 37:278–316. doi:10.1210/er.2015-1137.
  • Kjellmo CA, Karlsson H, Nestvold TK, Ljunggren S, Cederbrant K, Marcusson-Ståhl M, Mathisen M, Lappegård KT, Hovland A. 2018. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity. J Clin Lipidol. 12:193–202. doi:10.1016/j.jacl.2017.10.007.
  • Koliaki C, Liatis S, le Roux CW, Kokkinos A. 2017. The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord. 17:50. doi:10.1186/s12902-017-0202-6.
  • Kristensson FM, Andersson-Assarsson JC, Svensson P-A, Carlsson B, Peltonen M, Carlsson LMS. 2020. Effects of bariatric surgery in early- and adult-onset obesity in the prospective controlled Swedish obese subjects study. Diabetes Care. 43:860–866. doi:10.2337/dc19-1909.
  • Ludwig DS, Pollack HA. 2009. Obesity and the economy. JAMA. 301:533–535. doi:10.1001/jama.2009.52.
  • Mika A, Kaska L, Proczko-Stepaniak M, Chomiczewska A, Swierczynski J, Smolenski RT, Sledzinski T. 2018. Evidence that the length of bile loop determines serum bile acid concentration and glycemic control after bariatric surgery. Obes Surg. 28:3405–3414. doi:10.1007/s11695-018-3314-9.
  • Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F. 2012. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 366:1577–1585. doi:10.1056/NEJMoa1200111.
  • Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, Castagneto M, Bornstein S, Rubino F. 2015. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 386:964–973. doi:10.1016/S0140-6736(15)00075-6.
  • Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. 2001. Prevalence of besity, diabetes, and obesity-related health risk factors. JAMA. 289:76–79. doi:10.1001/jama.289.1.76.
  • Nelson RH. 2013. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care Clin Off Pract. 40:195–211. doi:10.1016/j.pop.2012.11.003.
  • Panunzi S, Carlsson L, De Gaetano A, Peltonen M, Rice T, Sjöström L, Mingrone G, Dixon JB. 2016. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care. 39:166–174. doi:10.2337/dc15-0575.
  • Qasim A, Turcotte M, de Souza RJ, Samaan MC, Champredon D, Dushoff J, Speakman JR, Meyre D. 2018. On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations. Obes Rev. 19:121–149. doi:10.1111/obr.12625.
  • Robert A, Al Dawish M, Braham R, Musallam M, Al Hayek A, Al Kahtany N. 2016. Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Curr Diabetes Rev. 13:59–64. doi:10.2174/1573399812666160126142605.
  • Shah A, Laferrère B. 2017. Diabetes after bariatric surgery. Can J Diabetes. 41:401–406. doi:10.1016/j.jcjd.2016.12.009.
  • Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, Bouchard C, Carlsson B, Karason K, Lönroth H, et al. 2014. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 311:2297–2304. doi:10.1001/jama.2014.5988.
  • Steinert RE, Peterli R, Keller S, Meyer-Gerspach AC, Drewe J, Peters T, Beglinger C. 2013. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity. 21:E660–E668. doi:10.1002/oby.20522.
  • van Greevenbroek MMJ, Schalkwijk CG, Stehouwer CDA. 2013. Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med. 71:174–187.
  • Wallenius V, Dirinck E, Fändriks L, Maleckas A, le Roux CW, Thorell A. 2018. Glycemic control after sleeve gastrectomy and roux-En-Y gastric bypass in obese subjects with type 2 diabetes mellitus. Obes Surg. 28:1461–1472. doi:10.1007/s11695-017-3061-3.
  • Yamamoto H, Kaida S, Yamaguchi T, Murata S, Tani M, Tani T. 2016. Potential mechanisms mediating improved glycemic control after bariatric/metabolic surgery. Surg Today. 46:268–274. doi:10.1007/s00595-015-1134-2.